Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Goletti

Showing results (131-140 of 310) with videos related to

Pageof 31
Sort By:
Pathogens (Basel, Switzerland)|January 28, 2026
Peptide MegaPools Approach to Evaluate the Dengue-Specific CD4 and CD8 T-Cell ResponseMarta Tiberi, Linda Petrone, Andrea Salmi, et al.
Infectious Disease Reports|December 22, 2023
Utility of Liver Biopsy in the Diagnosis and Management of Possible Drug-Induced Liver Injury in Patients Receiving Antituberculosis Therapy: A Retrospective StudyGina Gualano, Drieda Zace, Silvia Mosti, et al.
The European Respiratory Journal|January 28, 2022
Practices of therapeutic drug monitoring in tuberculosis: an international surveyIoana Margineanu, Onno Akkerman, Dario Cattaneo, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 25, 2022
Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020Ioana Margineanu, Kieran Rustage, Teymur Noori, et al.
The Journal of Infection|September 30, 2018
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in childrenMichela Sali, Danilo Buonsenso, Pamela D'Alfonso, et al.
Plos One|March 1, 2019
Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in ItalyGina Gualano, Paola Mencarini, Maria Musso, et al.
The Journal of Infection|February 26, 2020
Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infectionElisa Petruccioli, Teresa Chiacchio, Assunta Navarra, et al.
The European Respiratory Journal|June 27, 2020
On tuberculosis and COVID-19 co-infectionMarina Tadolini, José-María García-García, François-Xavier Blanc, et al.
Cell Death & Disease|August 5, 2023
The ubiquitin ligase TRIM32 promotes the autophagic response to Mycobacterium tuberculosis infection in macrophagesAlessandra Romagnoli, Martina Di Rienzo, Elisa Petruccioli, et al.
The European Respiratory Journal|May 27, 2017
Long-lasting tuberculous pleurisyElisa Petruccioli, Thomas J Scriba, Linda Petrone, et al.
Pageof 31

Showing results (131-140 of 310) with videos related to

Sort By:
Pageof 31
Pathogens (Basel, Switzerland)|January 28, 2026
Peptide MegaPools Approach to Evaluate the Dengue-Specific CD4 and CD8 T-Cell ResponseMarta Tiberi, Linda Petrone, Andrea Salmi, et al.
Infectious Disease Reports|December 22, 2023
Utility of Liver Biopsy in the Diagnosis and Management of Possible Drug-Induced Liver Injury in Patients Receiving Antituberculosis Therapy: A Retrospective StudyGina Gualano, Drieda Zace, Silvia Mosti, et al.
The European Respiratory Journal|January 28, 2022
Practices of therapeutic drug monitoring in tuberculosis: an international surveyIoana Margineanu, Onno Akkerman, Dario Cattaneo, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 25, 2022
Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020Ioana Margineanu, Kieran Rustage, Teymur Noori, et al.
The Journal of Infection|September 30, 2018
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in childrenMichela Sali, Danilo Buonsenso, Pamela D'Alfonso, et al.
Plos One|March 1, 2019
Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in ItalyGina Gualano, Paola Mencarini, Maria Musso, et al.
The Journal of Infection|February 26, 2020
Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infectionElisa Petruccioli, Teresa Chiacchio, Assunta Navarra, et al.
The European Respiratory Journal|June 27, 2020
On tuberculosis and COVID-19 co-infectionMarina Tadolini, José-María García-García, François-Xavier Blanc, et al.
Cell Death & Disease|August 5, 2023
The ubiquitin ligase TRIM32 promotes the autophagic response to Mycobacterium tuberculosis infection in macrophagesAlessandra Romagnoli, Martina Di Rienzo, Elisa Petruccioli, et al.
The European Respiratory Journal|May 27, 2017
Long-lasting tuberculous pleurisyElisa Petruccioli, Thomas J Scriba, Linda Petrone, et al.
Pageof 31